Loading clinical trials...
Loading clinical trials...
A Phase I Trial of Clofarabine in Combination With High-Dose Etoposide and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation for Patients With High-Risk or Refractory Non-Hodgkin's Lymphoma
Conditions
Interventions
clofarabine
Locations
1
United States
Indiana University Cancer Center
Indianapolis, Indiana, United States
Start Date
May 1, 2007
Primary Completion Date
November 1, 2010
Completion Date
November 1, 2010
Last Updated
September 11, 2014
NCT05618925
NCT06014073
NCT05370547
NCT02787239
NCT04497688
NCT00714259
Lead Sponsor
Indiana University School of Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions